Geert van Tetering

976 total citations
15 papers, 774 citations indexed

About

Geert van Tetering is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Geert van Tetering has authored 15 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Immunology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Geert van Tetering's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (4 papers) and T-cell and B-cell Immunology (4 papers). Geert van Tetering is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (4 papers) and T-cell and B-cell Immunology (4 papers). Geert van Tetering collaborates with scholars based in Netherlands, Germany and Hungary. Geert van Tetering's co-authors include Marc Vooijs, Ingrid Verlaan, Paul van Diest, Elsken van der Wall, Raphael Kopan, Jeanette H.W. Leusen, Anton Jan van Zonneveld, Victor Guryev, Linda van Laake and Eugène Berezikov and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Biochemical Journal.

In The Last Decade

Geert van Tetering

15 papers receiving 759 citations

Peers

Countries citing papers authored by Geert van Tetering

Since Specialization

Citations

This map shows the geographic impact of Geert van Tetering's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geert van Tetering with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geert van Tetering more than expected).

Fields of papers citing papers by Geert van Tetering

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geert van Tetering. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geert van Tetering. The network helps show where Geert van Tetering may publish in the future.

Co-authorship network of co-authors of Geert van Tetering

This figure shows the co-authorship network connecting the top 25 collaborators of Geert van Tetering. A scholar is included among the top collaborators of Geert van Tetering based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geert van Tetering. Geert van Tetering is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	The relevance of tumor target expression levels on IgA-mediated cytotoxicity in cancer immunotherapy 2024 ·Cancer Immunology Immunotherapy ·(unknown), (unknown), J.H. Marco Jansen, (unknown), Maaike Nederend, (unknown), (unknown), Matthias Peipp, Marianne Boes, Geert van Tetering, Jeanette H.W. Leusen	1
2	Enhancing IgA-mediated neutrophil cytotoxicity against neuroblastoma by CD47 blockade 2024 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), Maaike Nederend, (unknown), (unknown), (unknown), Judith Wienke, Geert van Tetering, Jeanette H.W. Leusen	5
3	IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma models 2023 ·Journal for ImmunoTherapy of Cancer ·(unknown), Mitchell Evers, Maaike Nederend, (unknown), Karli R. Reiding, Mirjam Damen, Albert J. R. Heck, (unknown), Ruud M. Ramakers, Gerard C. Krijger, Remmert de Roos, (unknown), Annelisa M. Cornel, Miranda P. Dierselhuis, (unknown), Mark de Boer, Thomas Valerius, Geert van Tetering, Jeanette H.W. Leusen, Friederike Meyer‐Wentrup	16
4	Sialic Acids on Tumor Cells Modulate IgA Therapy by Neutrophils via Inhibitory Receptors Siglec-7 and Siglec-9 2023 ·Cancers ·(unknown), (unknown), J.H. Marco Jansen, (unknown), (unknown), Lois A. Daamen, Thomas Valerius, Geert van Tetering, Jeanette H.W. Leusen	8
5	Targeting Myeloid Checkpoint Molecules in Combination With Antibody Therapy: A Novel Anti-Cancer Strategy With IgA Antibodies? 2022 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), Thomas Valerius, Geert van Tetering, Jeanette H.W. Leusen	14
6	Fc Engineering Strategies to Advance IgA Antibodies as Therapeutic Agents 2020 ·SHILAP Revista de lepidopterología ·Geert van Tetering, Mitchell Evers, (unknown), (unknown), Jeanette H.W. Leusen	45
7	Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing 2015 ·Cancer Immunology Research ·Arianne M. Brandsma, Toine ten Broeke, Maaike Nederend, Laura A.P.M. Meulenbroek, Geert van Tetering, Saskia Meyer, J.H. Marco Jansen, (unknown), Sietse Q. Nagelkerke, István Balázs Németh, Ruud Ubink, Gerard Rouwendal, Stefan Lohse, Thomas Valerius, Jeanette H.W. Leusen, Péter Boross	39
8	Simultaneous Targeting of FcgRs and FcaRI Enhances Tumor Cell Killing 2015 ·Arianne M. Brandsma, Maaike Nederend, Geert van Tetering, Saskia Meyer, (unknown), (unknown), Sietse Q. Nagelkerke, István Balázs Németh, Ruud Ubink, Gerard Rouwendal, Stefan Lohse, Thomas Valerius, Jeanette H.W. Leusen, Péter Boross	2
9	Anti-tumor activity of human IgG1 anti-gp75 TA99 mAb against B16F10 melanoma in human FcgammaRI transgenic mice 2014 ·Immunology Letters ·Péter Boross, J.H. Marco Jansen, Geert van Tetering, Maaike Nederend, Arianne M. Brandsma, Saskia Meyer, (unknown), Henk‐Jan van den Ham, Laura A.P.M. Meulenbroek, Simone de Haij, Jeanette H.W. Leusen	14
10	Ig A EGFR antibodies mediate tumour killing in vivo 2013 ·EMBO Molecular Medicine ·Péter Boross, Stefan Lohse, Maaike Nederend, J.H. Marco Jansen, Geert van Tetering, Michael Dechant, Matthias Peipp, Louise Royle, Li Phing Liew, Louis Boon, Nico van Rooijen, Wim K. Bleeker, Paul W.H.I. Parren, Jan G. J. van de Winkel, Thomas Valerius, Jeanette H.W. Leusen	101
11	Proteolytic Cleavage of Notch: “HIT and RUN” 2011 ·Current Molecular Medicine ·Geert van Tetering, Marc Vooijs	66
12	Cleavage of Notch1 by granzyme B disables its transcriptional activity 2011 ·Biochemical Journal ·Geert van Tetering, Niels Bovenschen, Jan Meeldijk, P. J. van Diest, Marc Vooijs	14
13	Metalloprotease ADAM10 is required for Notch1 site 2 cleavage. 2010 ·Journal of Biological Chemistry ·Geert van Tetering, Paul van Diest, Ingrid Verlaan, Elsken van der Wall, Raphael Kopan, Marc Vooijs	3
14	Metalloprotease ADAM10 Is Required for Notch1 Site 2 Cleavage 2009 ·Journal of Biological Chemistry ·Geert van Tetering, Paul van Diest, Ingrid Verlaan, Elsken van der Wall, Raphael Kopan, Marc Vooijs	218
15	Many novel mammalian microRNA candidates identified by extensive cloning and RAKE analysis 2006 ·Genome Research ·Eugène Berezikov, Geert van Tetering, Mark Verheul, José van de Belt, Linda van Laake, Joost B. Vos, Robert E. Verloop, Marc van de Wetering, Victor Guryev, Shuji Takada, Anton Jan van Zonneveld, Hiroyuki Mano, Ronald H.A. Plasterk, Edwin Cuppen	228

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact